Physician profile
Tabitha D Delo
NPI 1770777575
$615.52
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.46 · 2020: $360 · 2021: $132 · 2023: $25.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $177.42 | 2019-2021 | |
| Abbvie INC. | $143.52 | 2019-2021 | |
| Avion Pharmaceuticals | $101.55 | 2020-2021 | |
| Lupin INC. | $77.42 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.46 | 2020 | |
| Coopersurgical, INC. | $25.00 | 2023 | Summit Doppler |
| Celgene Corporation | $19.90 | 2019 | |
| Merck Sharp & Dohme LLC | $15.43 | 2019 | |
| Therapeuticsmd, INC. | $14.51 | 2019 | |
| Allergan, INC. | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Delo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.